Abselion logo

Abselion

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$8.4M


Abselion develops automated analytical instruments for at-line protein quantification in biopharmaceutical research and production.

Total Funding

$8.4M

Headquarters

Cambridge, United Kingdom

Founded

N/A

Focus Areas

Automated
Analytical
Instrument
Protein
Quantification
Biopharmaceutical

Investors

BGF logo
M Ventures logo
Untitled Ventures logo
R42 logo
BioProcess 360 Partners logo